Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications

K Bui, W Earley, S Nyberg - Current medical research and opinion, 2013 - Taylor & Francis
Objectives: A series of studies were conducted to guide the development and characterise
the pharmacokinetics of extended-release quetiapine fumarate (quetiapine XR), a once …
被引用次数：49 相关文章

[引用][C] Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications

K BUI, W EARLEY, S NYBERG - Current medical research …, 2013 - pascal-francis.inist.fr
Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine
XR): clinical implications CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.

K Bui, W Earley, S Nyberg - Current Medical Research and Opinion, 2013 - europepmc.org
Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine
XR): clinical implications. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications

K Bui, W Earley, S Nyberg - Current medical research and …, 2013 - pubmed.ncbi.nlm.nih.gov
Objectives A series of studies were conducted to guide the development and characterise
the pharmacokinetics of extended-release quetiapine fumarate (quetiapine XR), a once …

[引用][C] Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications

K BUI, W EARLEY, S NYBERG - Current medical research and opinion, 2013 - Informa